---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-006053"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2024-08-28T23:59:59+00:00"
generated_at: "2026-05-31T07:08:30.236298+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals announces 1-for-20 reverse stock split effective Aug 29 to maintain Nasdaq listing

## Summary
- Authorized shares increased from 24M to 50M; reverse split ratio 1:20 effective Aug 29, 2024 at 5pm EDT.
- Post-split common shares outstanding ~1M; trading begins on split-adjusted basis Aug 30, 2024.
- Split intended to meet Nasdaq $1 minimum bid price requirement by Sept 16, 2024; no assurance of compliance.
- Stockholders re-elected Philippe Weigerstorfer and Amy Trombly as Class I directors; reincorporation to Nevada not approved.
- All proposals at annual meeting approved except reincorporation; auditor ratified.

## SEC filing metadata
- accession: 0001683168-24-006053
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2024-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316824006053/0001683168-24-006053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316824006053/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-006053
- JSON: https://secwatch.observer/filing/0001683168-24-006053.json
- Plain text: https://secwatch.observer/filing/0001683168-24-006053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.